Rheumatoid arthritis and kidney disease
Authors:
J. Závada
Authors‘ workplace:
Revmatologický ústav a Revmatologická klinika 1. LF UK, Praha
Published in:
Čes. Revmatol., 28, 2020, No. 1, p. 32-38.
Category:
Review Article
Overview
The risk of developing chronic kidney disease (CKD) in patients with rheumatoid arthritis (RA) is increased. While previously the main cause of CKD in RA patients was toxicity of treatment and secondary amyloidosis, with the introduction of modern therapies the situation has changed significantly and the increased incidence of CKD in RA patients is now mainly associated with the presence of comorbid conditions and older age. The presence of CKD in patients with RA increases the risk of developing cardiovascular disease and premature death. In patients with CKD, RA treatment should be adjusted according to the parameters of renal function.
Keywords:
rheumatoid arthritis – chronic kidney disease – glomerulonephritis – disease modifying drugs
Sources
1. Kapoor T, Bathon J. Renal Manifestations of Rheumatoid Arthritis. Rheum Dis Clin North Am 2018; 44(4): 571–584.
2. Horak P, Smrzova A, Krejci K, et al. Renal manifestations of rheumatic diseases. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013; 157(2): 98–104.
3. Helin HJ, Korpela MM, Mustonen JT, Pasternack AI. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 1995; 38(2): 242–247.
4. Vinicki JP, Pellet SC, De Rosa G, et al. Analysis of 65 Renal Biopsies From Patients With Rheumatoid Arthritis (1976–2015): Change in Treatment Strategies Decreased Frequency and Modified Histopathological Findings. J Clin Rheumatol 2015; 21(7): 335–340.
5. Pollak V, Pirani C, Steck I, et al. The kidney in rheumatoid arthritis: studies by renal biopsy. Arthritis Rheum 1962; 5: 1–9.
6. Horii Y, Muraguchi A, Iwano M, et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 1989; 143(12): 3949–3955.
7. Couderc M, Tatar Z, Pereira B, et al. Prevalence of Renal Impairment in Patients With Rheumatoid Arthritis: Results From a Cross-Sectional Multicenter Study. Arthritis Care Res (Hoboken) 2016; 68(5): 638–644.
8. Paudyal S, Yang FM, Rice C, et al. End-stage renal disease in patients with rheumatoid arthritis. Semin Arthritis Rheum 2017; 46(4): 418–422.
9. Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL. Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis 2014; 63(2): 206–213.
10. Chiu HY, Huang HL, Li CH, et al. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications – A National Population-Based Cohort Study. PLoS One 2015; 10(9): e0136508.
11. Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y. Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis. PLoS One 2016; 11(8): e0160225.
12. Sumida K, Molnar MZ, Potukuchi PK, et al. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease. Kidney Int 2018; 93(5): 1207–1216.
13. Kim HW, Lee CK, Cha HS, Choe JY, Park EJ, Kim J. Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease. Rheumatol Int 2015; 35(4): 727–734. doi:10.1007/s00296-014-3146-4 [Epub 2014 Oct 8].
14. Wu CL, Chang CC, Kor CT, et al. Hydroxychloroquine Use and Risk of CKD in Patients with Rheumatoid Arthritis. Clin J Am Soc Nephrol 2018; 13(5): 702–709.
15. Möller B, Pruijm M, Adler S, Scherer A, Villiger PM, Finckh A. Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis 2015; 74(4): 718–723.
16. Tokoroyama T, Ando M, Setoguchi K, Tsuchiya K, Nitta K. Prevalence, incidence and prognosis of chronic kidney disease classified according to current guidelines: a large retrospective cohort study of rheumatoid arthritis patients. Nephrol Dial Transplant 2017; 32(12): 2035–2042.
17. Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y. Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis. J Cardiol 2018; 71(3): 277–283.
18. van Sijl AM, van den Oever IA, Peters MJ, et al. Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study. Ann Rheum Dis 2012; 71(3): 341–344.
19. Daoussis D, Panoulas VF, Antonopoulos I, et al. Cardio-vascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69(3): 517–521.
Labels
Dermatology & STDs Paediatric rheumatology RheumatologyArticle was published in
Czech Rheumatology
2020 Issue 1
Most read in this issue
- Doporučení České revmatologické společnosti 2020 k perioperační úpravě léčby zánětlivých revmatických onemocnění
- Magnetic resonance imaging in diagnostics of idiopathic inflammatory myopathies
- Rheumatoid arthritis and kidney disease
- Statin--induced necrotizing autoimmune myopathy as an unusual cause of extreme elevation of cardiac markers in a patient with muscle weakness and swelling